Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience.

Hartinger, Jan Miroslav; Satrapová, Veronika; Hrusková, Zdenka; Tesar, Vladimír

Hartinger, Jan Miroslav; Satrapová, Veronika; Hrusková, Zdenka; Tesar, Vladimír.

Afiliação

Hartinger JM; Institute of Pharmacology, Department of Clinical Pharmacology and Pharmacy, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Satrapová V; Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Hrusková Z; Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Tesar V; Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Eur J Hosp Pharm ; 26(4): 210-213, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31338169

Palavras-chave

anca associated vasculitis; infusion related adverse events; membranous nephropathy; rapid infusion; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Eur J Hosp Pharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google